World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Group
Changes underway in the pharmaceutical industry.
12/06/2007
Old ways are disappearing, and the pharmaceutical industry will look very different ten years from now from what it is today.
Grouped Articles
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12.16.2013
Big Pharma Faces Grim Prognosis
Wall Street Journal 12.06.2007
New York Times 06.25.2009
New Conflict Rules at Medical Journals
Wall Street Journal 10.14.2009
Using a Pfizer Grant, Courses Aim to Avoid Bias
New York Times 01.11.2010
Drug Firms Feel Pinch From Europe
Wall Street Journal 07.29.2010
U.S. to Tell Drug Makers to Disclose Payments to Doctors
New York Times 01.16.2012
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05.08.2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
